1801 - 1825 of 6570 Results
Title
Year
-
OPENTitle: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in SolutionJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 17Issue #: 13Start Page: 12325End Page: 12335Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.3c01393Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c01393Citation Count: 51
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 65
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 92
-
OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 47End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 58
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 26
-
OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4598062Citation Count: 68
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 26
-
OPENTitle: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29283Best OA location URL: https://doi.org/10.1002/mds.29283Citation Count: 33
-
OPENTitle: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic NeuronsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 75End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005Best OA location URL: http://www.cell.com/article/S2213671119304448/pdfCitation Count: 63
- Endolysosomal cholesterol export: More than just NPC12022OPENTitle: Endolysosomal cholesterol export: More than just NPC1Journal Name: BioEssaysPublisher: WileyVol: 44Issue #: 10Start Page: e2200111End Page: e2200111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/bies.202200111Citation Count: 20
-
OPENTitle: Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative StudyJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 6Start Page: 1580End Page: 1585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70236Best OA location URL: https://doi.org/10.1002/mds.70236Citation Count: 0
-
OPENTitle: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromeJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 2Start Page: 1038End Page: 1049Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13506Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13506Citation Count: 13
-
OPENTitle: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in MiceJournal Name: EBioMedicinePublisher: Elsevier BVVol: 29Issue #:Start Page: 13End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdfCitation Count: 32
-
OPENTitle: Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicityJournal Name: Archives of ToxicologyPublisher: Springer Science and Business Media LLCVol: 92Issue #: 7Start Page: 2353End Page: 2367Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00204-018-2222-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00204-018-2222-z.pdfCitation Count: 19
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 71
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6235675Citation Count: 51
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 20
-
OPENTitle: Addressing the Challenges of Translating LRRK2 Biology into Disease‐Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange InitiativeJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70397Best OA location URL: https://doi.org/10.1002/mds.70397Citation Count: 0
-
OPENTitle: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased LigandsJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 11Issue #: 3Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074212Citation Count: 14
- The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease2017OPENTitle: The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 55Issue #: 6Start Page: 5125End Page: 5136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-017-0748-3Citation Count: 25
-
OPENTitle: Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagusJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 3Start Page: 1513End Page: 1520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00432.2014Best OA location URL: http://doi.org/10.1152/jn.00432.2014Citation Count: 20
- Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles2024OPENTitle: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.92775.3Best OA location URL: https://doi.org/10.7554/elife.92775.3Citation Count: 14
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870749Citation Count: 1
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 19
-
OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 44